{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2007"],"condition":["Unresectable advanced/recurrent colorectal cancer"],"disease":["Unresectable Advanced/recurrent Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2616834"],"location":["Japan"],"study_start_month":["8"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen","description":"Interventions: Irinotecan+S-1, repeated every 3 weeks.\nPrimary outcome(s): RR\nStudy Design: Single arm Non-randomized","dates":{"creation":"2007-08-15"},"accession":"2616834","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000001342"]}}